HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Zomedica Pharmaceuticals Corp. (ZOM)
0.0803  -0.001  (-1.23%) 10-19 20:31
Open: 0.081 High: 0.0825
Pre.close: 0.0813 Low: 0.08
Volume: 13,444,439 Ave vol: 31,955,503
52w High: 0.499 52w Low: 0.07
MA(50): 0.099 MA(200): 0.158
EPS: -0.109 P/E Ratio: 0
Company profile
Exchange: AMEX
Sector: Healthcare
Industry: Drug Manufacturers General Specialty & Generic
Website: http://www.zomedica.com/
Market Cap (M): 44
Shares Out (M): 551
Zomedica Pharmaceuticals Corp. operates as a development stage veterinary diagnostic and pharmaceutical company. The company is headquartered in Ann Arbor, Michigan and currently employs 27 full-time employees. The firm is engaged in developing products for companion animals, such as canine, feline, and equine by focusing on needs of clinical veterinarians. The company is focused on developing three diagnostic platforms, a Bulk Acoustic Wave sensor-based veterinary point-of-care diagnostic platform for performing immunodiagnostic testing, a Raman spectroscopy-based point-of-care diagnostic platform for the detection of pathogens, and liquid biopsy assays for the detection of cancer, along with related consumables. The Company’s TRUFORMA product candidate is an investigational device being developed as a point-of-care biosensor platform. ZM-020 is its diagnostic platform being developed to screen for a range of pathogens in companion animal feces, urine, respiratory, and dermatological samples. The company is developing ZM-017 as a canine cancer liquid biopsy platform.
Technical analysis
Overall: Neutral
MA: Bearish MACD: Bearish
KDJ: Bearish RSI: Bearish
Target 1: 0.11 Target 2: 0.13
Resist 1: 0.10 Resist 2: 0.11
Support 1: 0.07 Support 2: 0.06
Company key metrics
Revenue per Share: 0
Net Income per Share: -0.1861
Cash per Share: 0.0048
Book Value per Share: 0.0197
Price to Sales: 0
Price to Book Value: 12.3776
Earnings Yield: -0.7628
Dividend Yield: 0
Debt to Equity: 0.9962
Debt to Assets: 0.4991
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.